Showing results 1 to 9 of 9
Title | Author(s) | Issue Date | |
---|---|---|---|
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | ||
Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases Journal:Proceedings of the National Academy of Sciences | 2021 | ||
2006 | |||
2008 | |||
2011 | |||
FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells Journal:Cancer Letters | 2011 | ||
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer Journal:Proceedings of the National Academy of Sciences | 2014 | ||
2011 | |||
Molecular cloning and characterization of a hypoxia-responsive CITED3 cDNA from grass carp Journal:Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology | 2003 |